DJ Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ slipped 1.60% to $423.24 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.04% to 7,135.95 and Dow Jones Industrial Average falling 0.57% to 48,861.81.
Vertex Pharmaceuticals Inc. closed 17.14% short of its 52-week high of $510.77, which the company reached on April 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. $(ABBV)$ rose 3.14% to $203.89, Krystal Biotech Inc. (KRYS) fell 3.46% to $259.95, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 5.30% to $8.40.
Trading volume (1.1 M) remained 245,546 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 29, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 29, 2026 16:39 ET (20:39 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.